In nervous tissues, phosphatidylcholine (PC) plays an important not role only as an essential component of cell membranes including myelin but as the source of choline and acetylcholine.
Therefore, it is essential for nerve cells to regulate PC biosynthesis.
The present paper looks at phosphatidylethanolamine methyl transferase (PEMT), an enzyme responsible for PC biosynthesis, in the brain, and *Present address : Department of Biochemistry , Faculty of Science, Nara Women's University, Kitauoyanishimachi, Nara 630.
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Phosphatidylethanolamine methyltransferase in brain during myelination
The activity of PEMT, which catalyzes PC synthesis by the successive methylation of phosphatidylethanolamine (PE) with S-adenosylmethionine (AdoMet) as a methyl donor, has been thought to be lacking or to be too low to play a significant role in nervous tissue1-3?. Instead, the so-called de novo synthesis of PC from diglyceride and CDP-choline was believed to be the sole pathway for PC synthesis in these cells (Fig. 1 ). This hypothesis was based on the fact that PEMT was not detectable in the brains of adult animals, in which their myelination and almost all PC synthesis had already been terminated). However, one would expect to find increased activity of the enzymes responsible for PC synthesis and the existence of PEMT in the brain during the active myelinating period. Two experimental systems were used as actively myelinat ing brains ; developing fetal brains and remyelinating adult brains after druginduced demyelination. Table 1 shows the existence of PEMT activity in the developing brain which was actively synthesizing PC. This activity suddenly decreased to a negligible level after birth and was hardly detected in adult brain. These results led us to conclude that the actively myelinating brain has a signifi cant amount of PEMT, and that the enzyme responsible for PC synthesis plays an essential role in myelination. In order to confirm this conclusion, we determined PEMT activity in the brains of mice administered cuprizone, which was reported to have a reversible demyelinating effect on the central nervous systems). The results, as shown in Table 1 , demonstrate that PEMT activity was found even at the early stage of demyelination and that it increased gradually throughout the This is probably also true in the case of human.
Phosphatidylethanolamine methyltransferase in brain of diabetic mouse PEMT activity in the diabetic mouse brain was determined as a possible marker of demyelination. As animal models for diabetes mellitus, we used genetically transmitted diabetic mice C57BL/KsJ-db/db, and streptozotocin induced diabetic mice. Enzyme activity was much lower in the brains of these mice than in those of developing and demyelinating mice but significantly higher than in normal adult mouse brains ( Table 2 ). The neuropathy hitherto reported in diabetic patients has been peripheral and not demyelinating. Since the peripheral nerve is too small to allow the detection of PEMT activity, it has not been possible to assay it up to now. However, it is evident that PC synthesis by the methylation of PE occurs in the central nervous tissue of diabetic mice. Some possible explanations for this might be ; [I] Demyelination occurs in the central nervous tissue of diabetics. To clarify this possibility, morphological evidence would be required.
[II] Demyelination in the central nervous tissue of diabetics may not be so severe that the resulting PEMT activity would be sufficient to prevent the onset of neuropathy. This hypothesis is thought to be more likely and agrees well with the morphological findings. If the latter possibility is correct, the administration to diabetics of a methyl donor utilizable by PEMT might be important.
[III] The increases in PEMT and PC synthesis were not related to myelination but rather served as a pathway for the synthesis of choline. In nervous tissue choline is essential for the synthesis of the neuro transmitter, acetylcholine. Choline also stimulates cellular growth in some living organisms. Nerve cells might require this growth factor in order to protect the brain not only from demyelination but from any kind of damage caused by hyperglycemia or hypoinsulinemia.
Metabolic fate of methyl group of mecobalamin
The increase of PEMT activity in the brain during the developing, de-and remyelinating, and diabetic states has been elucidated. But further explanation is needed as to the supply of methyl donor to PEMT and the further metabolism of the product, PC. A large number of clinical reports have recently appeared concerning the effect of McB12 on peripheral neuropathy. Because McB12 was thought to be a methyl donor, the metabolic fate of the methyl group of McB12 was studied in fetal Wistar rat brain slices. Fig. 2 shows the incorporation of radioac tive methyl groups into the fractions of methionine, PC, choline, and acetylcho line. The radioactivity of the methionine fraction increased rapidly during the initial phase of the 2 hr incubation but slowed down thereafter. This phenomenon suggests that methionine was the initial product of the methyl transfer from McB12 and that the former was further metabolized into protein and other compounds via AdoMet. These reactions are summarized in Fig. 3 . PC, choline, and acetylcholine are essential to the functions of the nervous system. The finding that these constituents and McB12 were metabolically linked by PEMT and that this enzyme increased during the physiologically (development) and pathologically (demyelination-remyelination, and diabetes) active period of nervous tissues may suggest the essential role of PEMT in nervous tissue as well as the reason for the effectiveness of McB12 in the therapy of neuropathy including neuropathy of diabetic origin.
